Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Documenting the Effectiveness of Hydroxyurea (HU) To Treat Sickle Cell Disease (SCD) in the Community Setting.

Sophie Lanzkron, MD, Carlton Haywood, Jr., MA, Peter Fagan, MD

Blood (2007) 110 (11): 956.

https://doi.org/10.1182/blood.V110.11.956.956

Published: 2007

Journal Articles

Sickle Cell Disease Mortality in the United States: Age at Death and Contributing Causes.

Carlton Haywood, Jr., MA, Sophie Lanzkron, MD

Blood (2007) 110 (11): 81.

https://doi.org/10.1182/blood.V110.11.81.81

Published: 2007

Journal Articles

Gender and Regional Differences in In-Hospital Mortality in Patients with Sickle Cell Anemia (SCA) in the United States: Results from the Nationwide Inpatient Sample (NIS) 1993-2003.

Carlton Haywood, Jr., MA, Sophie Lanzkron, MD

Blood (2006) 108 (11): 461.

https://doi.org/10.1182/blood.V108.11.461.461

Published: 2006

Journal Articles

Costs of Care for Hospitalized Adults with Sickle Cell Anemia (SCA) in Maryland (MD) Have Skyrocketed: 1995–2003.

Sophie Lanzkron, MD, Carlton Haywood, Jr., MA, George J. Dover, MD

Blood (2005) 106 (11): 2237.

https://doi.org/10.1182/blood.V106.11.2237.2237

Published: 2005

Journal Articles

Regional and Age Group Differences in Sickle Cell Anemia Hospitalization Rates among African-American Adults: 1990-2002.

Carlton Haywood, Jr., MA, Sophie Lanzkron, MD

Blood (2005) 106 (11): 2255.

https://doi.org/10.1182/blood.V106.11.2255.2255

Published: 2005

Journal Articles

Gender Differences in Hospitalized Patients with Sickle Cell Disease (SCD): 1990–2002.

Carlton Haywood, Jr., MA, Sophie Lanzkron, MD

Blood (2005) 106 (11): 2256.

https://doi.org/10.1182/blood.V106.11.2256.2256

Published: 2005

NARROW

Documenting the Effectiveness of Hydroxyurea (HU) To Treat Sickle Cell Disease (SCD) in the Community Setting.

Sickle Cell Disease Mortality in the United States: Age at Death and Contributing Causes.

Gender and Regional Differences in In-Hospital Mortality in Patients with Sickle Cell Anemia (SCA) in the United States: Results from the Nationwide Inpatient Sample (NIS) 1993-2003.

Costs of Care for Hospitalized Adults with Sickle Cell Anemia (SCA) in Maryland (MD) Have Skyrocketed: 1995–2003.

Regional and Age Group Differences in Sickle Cell Anemia Hospitalization Rates among African-American Adults: 1990-2002.

Gender Differences in Hospitalized Patients with Sickle Cell Disease (SCD): 1990–2002.

Email alerts

ASH Publications

American Society of Hematology

Documenting the Effectiveness of Hydroxyurea (HU) To Treat Sickle Cell Disease (SCD) in the Community Setting.

Sickle Cell Disease Mortality in the United States: Age at Death and Contributing Causes.

Gender and Regional Differences in In-Hospital Mortality in Patients with Sickle Cell Anemia (SCA) in the United States: Results from the Nationwide Inpatient Sample (NIS) 1993-2003.

Costs of Care for Hospitalized Adults with Sickle Cell Anemia (SCA) in Maryland (MD) Have Skyrocketed: 1995–2003.

Regional and Age Group Differences in Sickle Cell Anemia Hospitalization Rates among African-American Adults: 1990-2002.

Gender Differences in Hospitalized Patients with Sickle Cell Disease (SCD): 1990–2002.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only